Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis

Technology appraisal guidance
Reference number: TA276
Published: 27 March 2013

Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Emma Lake and Nikki Samsa (patient experts) nominated by the Cystic Fibrosis Trust - joint submission

Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Emma Lake and Nikki Samsa (patient experts) nominated by the Cystic Fibrosis Trust - joint submission

Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Emma Lake and Nikki Samsa (patient experts) nominated by the Cystic Fibrosis Trust - joint submission
25 January 2013
(41.07 Kb 11 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 24 January 2013